Search
Pyronaridine
go.drugbank.com/drugs/DB12975InvestigationalPyronaridine has been investigated for the treatment of Malaria.
V591
go.drugbank.com/drugs/DB16438InvestigationalThrough Merck’s acquisition of Thermis in May 2020, they were able to leverage Thermis’ platform knowledge and accelerate the development of V591 to phase I clinical trials (NCT04498247)[L30593]. … The V591 vaccine, part of Merck’s COVID-19 vaccine programming, was developed using a modified measles vaccine virus as a vector for COVID-19 antigen delivery[L30593].
α-Methylacetylfentanyl
go.drugbank.com/drugs/DB01532ExperimentalIllicitα-Methylacetylfentanyl is an analog of fentanyl with opioid analgesic properties. … anhydride for the production of chemical propionic anhydride in the synthesis.
Conteltinib
go.drugbank.com/drugs/DB21262InvestigationalConteltinib has a monoisotopic molecular weight of 635.34 Da. … The usage of the INN stem '-tinib' in the name indicates that Conteltinib is a tyrosine kinase inhibitor.
Pritelivir
go.drugbank.com/drugs/DB11844InvestigationalPritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.
BI-765063
go.drugbank.com/drugs/DB17482InvestigationalBI-765063 is a humanized IgG4 monoclonal antibody antagonist of signal regulatory protein α (SIRPα).
EXOB-001
go.drugbank.com/drugs/DB18257ExperimentalEXOB-001 consists of extracellular vesicles derived from cultured human umbilical cord mesenchymal stromal cells.
KT-253
go.drugbank.com/drugs/DB18487InvestigationalKT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2).
PRG-A01
go.drugbank.com/drugs/DB18613InvestigationalPRG-A01 is a novel inhibitor of Cu, Zn-superoxide dismutase (SOD1) misfolding and aggregation.
Glial growth factor 2
go.drugbank.com/drugs/DB12841InvestigationalGlial growth factor 2 has been used in trials studying the treatment of Heart Failure.